导师风采
周道斌
个人信息
Personal Information
- 性别：男
- 导师类型：博导
- 职称：主任医师
- 该职称任职时间：2000-03-01
联系方式
Contact Information
- 所属院系：北京协和医院
- 所属专业：
- 邮箱 : zhoudb@pumch.cn
- 工作电话 : 13901113623
个人简介
Personal Profile
周道斌，男，55岁，现为北京协和医院血液科主任医师，博士生导师。长期从事临床工作。研究方向：血液肿瘤、造血干细胞移植。
团队简介
Team Profile
周道斌，男，55岁，现为北京协和医院血液科主任医师，博士生导师。长期从事临床工作。研究方向：血液肿瘤、造血干细胞移植。
- 研究方向Research Directions
淋巴瘤发病机制研究
- 在校研究生Current Graduate Students
硕士研究生 2 名，博士研究生 1 名
- 科研项目Research Projects
| # | 项目名称 | 起止日期 | 金额 | 项目类型 | 本人角色 |
|---|---|---|---|---|---|
| 1 | 嵌合抗原受体T细胞（CAR-T）治疗血液肿瘤的临床研究及机制探讨 | 2022-12-01 —— 2025-11-01 | 主持的企业/行业委托重大项目 | 主持人 | |
| 2 | HADC抑制剂对外周T细胞淋巴瘤PD-1/PD-L1免疫逃逸信号通路调控机理的研究 | 2020-01-01 —— 2023-12-01 | 主持在研的国家或省部级科研项目 | 主持人 |
- 发表论文Papers
| # | 论文题目 | 期刊名称 | 发表年份 | 论文署名 |
|---|---|---|---|---|
| 1 | Evaluation of Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenstr?m’s Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study | EClinicalMedicine | 2022-10-04 | 通讯作者 |
| 2 | Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk Patients | Journal of Oncology | 2022-11-17 | 通讯作者 |
| 3 | Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events | THORACIC CANCER | 2020-02-01 | 通讯作者 |
| 4 | Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment | CHINESE MEDICAL JOURNAL | 2020-06-01 | 通讯作者 |
| 5 | Long-term treatment response to PD-1 blockade therapy in a patient with DLBCL relapsed after anti-CD19 chimeric antigen receptor T cell treatment. | ANNALS OF HEMATOLOGY | 2020-04-01 | 通讯作者 |
| 6 | A Case of Reversible Cerebral Vasoconstriction Syndrome Triggered by High-Dose Methotrexate in a Boy With Lymphoma | HEADACHE | 2020-09-01 | 通讯作者 |
| 7 | Extranodal NK/T-Cell Lymphoma Occurring Primarily in the Eyes and with Central Nervous System Relapse | Cancer Manag Res | 2021-08-01 | 通讯作者 |
| 8 | Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of three cases | Hematology | 2021-09-01 | 通讯作者 |
| 9 | Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study | AMERICAN JOURNAL OF HEMATOLOGY | 2020-05-01 | 通讯作者 |
| 10 | Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study | AMERICAN JOURNAL OF HEMATOLOGY | 2020-01-01 | 通讯作者 |
| 11 | The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma | Blood Cancer Journal | 2023-12-14 | 通讯作者 |
| 12 | The role of upfront lenalidomide maintenance for primary central nervous system lymphoma following first-line methotrexate treatment: A retrospective study | Cancer Medicine | 2024-05-13 | 通讯作者 |
| 13 | Efficacy and Safety of BTKis in Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis | Cancers | 2024-02-21 | 通讯作者 |
| 14 | Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy | Cancers | 2023-07-27 | 通讯作者 |
| 15 | Improvement of the hematologic toxicities of ruxolitinib in patients with MPN-associated myelofibrosis using a combination of thalidomide, stanozolol and prednisone | Hematology | 2019-01-01 | 通讯作者 |
| 16 | Circulating PD-1 (+) cells may participate in immune evasion in peripheral T-cell lymphoma and chidamide enhance antitumor activity of PD-1 (+) cells. | Cancer Medicine | 2019-08-01 | 通讯作者 |
| 17 | Predicting worse survival for newly diagnosed T cell 1ymphoma based on the decreased baseline CD16-/CD16+ monocyte ratio | Scientific Report | 2020-05-01 | 通讯作者 |
| 18 | Risk of hepatitis B virus reactivation following ruxolitinib treatment in patients with myeloproliferative neoplasms | Hematology | 2021-06-01 | 通讯作者 |
| 19 | Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis | AMERICAN JOURNAL OF HEMATOLOGY | 2022-02-01 | 通讯作者 |
- 科研获奖Research Awards
无
- 研究成果Research Findings
无